Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Trulicity (dulaglutide) and Wegovy (semaglutide) are both GLP-1 receptor agonists injected once a week and both help lower the risk of heart problems. However, they have different FDA-approved uses. Trulicity is approved for managing Type 2 diabetes in people 10 years and older and for reducing heart-related risks in adults with Type 2 diabetes. Wegovy, on the other hand, is approved for long-term weight management in adults and children 12 years and older with certain BMI criteria and also for reducing heart risks in adults with heart disease and a larger body size. Both are only available as a branded medication. Common side effects for both include nausea and stomach pain, but Wegovy tends to cause more nausea thanTrulicity. Both medications carry a risk of thyroid cancer and pancreatitis, and neither are recommended if you have a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2.
Trulicity (dulaglutide)
Wegovy (semaglutide)
Trulicity (dulaglutide)
Wegovy (semaglutide)
Summary of Trulicity vs. Wegovy
Summary for GLP-1 agonist
Prescription only
Trulicity (dulaglutide) is a glucagon-like peptide-1 (GLP-1) agonist that helps control blood sugar in people 10 years and older with Type 2 diabetes. It's also approved to lower the risk of heart problems like heart attacks, strokes, and heart-related death in certain adults with Type 2 diabetes. The medication is injected under the skin once a week. Common side effects include nausea, vomiting, diarrhea, and stomach pain. When taken with certain diabetes medications like insulin, there's a higher risk of low blood sugar (hypoglycemia).
Summary for GLP-1 agonist
Prescription only
Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist. It comes in prefilled pens you use to inject the medication under the skin once a week. Wegovy (semaglutide) also comes as tablets that are swallowed once a day. This medication is approved for weight loss in some people. It can help lower the risk of heart attack, stroke, and death due to heart problems in adults with a larger body size and heart disease. The pens are also approved for certain adults with a liver problem called metabolic dysfunction-associated steatohepatitis (MASH). The medication works best when taken with a lower-calorie diet and regular exercise. Side effects include nausea, diarrhea, and stomach pain.
Indications of Trulicity vs. Wegovy
Indications for
•Manage Type 2 diabetes in people 10 years and older, along with diet and exercise
•Lower the risk of heart problems like heart attack, stroke, or death in adults with Type 2 diabetes who have heart disease or heart-related risk factors